Ligand Pharmaceuticals Inc director Martine Zimmermann sells $636,336 in stock
2,000 shares sold on the open market on Nov 12, at about $318.17 each.
Martine Zimmermann, a director of Ligand Pharmaceuticals Inc (LGND), sold 2,000 shares on Nov 12 at an average price of $318.17, a total of about $640,000, according to a Form 4 filed with the SEC on Nov 16.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. It is the eighth insider sale at Ligand Pharmaceuticals Inc reported in the last 90 days.
The filing came 4 days after the trade. After the trade, the filing lists 1,782 shares held.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Ligand Pharmaceuticals Inc (LGND) |
|---|---|
| Insider | Martine Zimmermann |
| Role | Director |
| Transaction | Open-market sale (code S) |
| Shares | 2,000 |
| Average price | $318.17 |
| Value | $636,336 |
| Trade date | Nov 12, 2026 |
| Filed with the SEC | Nov 16, 2026, 4:16 PM ET |
| Shares held after | 1,782 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See this filing row by row in Insider Stock Trader
See earlier insider stories on Ligand Pharmaceuticals Inc · Follow LGND for the next insider trade
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.